Boston Psychedelic Society

Christina O'Flaherty, PsyD

Founder

Christina is a clinical psychologist, meditation instructor, and licensed psilocybin facilitator in Oregon. She has specialized training in PTSD, having completed her clinical training at the Brooklyn VA and her postdoctoral year at NYPD after 9/11. Her background in trauma and her spiritual affinity led her to psychedelic medicine. She completed a certificate program in psychedelic research and therapy in 2025 and participates in ongoing practical training. She believes in the power of connection & community.

Tunde Aideyan, PhD

Co-Founder

Tunde is a psychologist licensed in the Commonwealth of Massachusetts and an instructor at Northeastern University, where he teaches community psychology. Inspired by community mental health, his clinical work focuses on serving diverse populations facing chronic mental distress, socioeconomic marginalization, and systemic barriers to care. His formal training also includes a psychedelics certificate program through the California Institute of Integral Studies, and he has previously published a reader's guide to microdosing in Aeon Magazine. Through his work with BPS, Tunde hopes to apply his expertise in community mental health and community psychology to advance innovative mental health treatments, promote equitable access to entheogens and plant medicines, and help nurture a robust network of likeminded people.

Willow Rose

BPS Leadership

Willow is a community builder and enthusiastic supporter of this space. She is a graduate of the California Institute of Integral Studies psychedelic-assisted therapy certificate program and has a background in IFS. She hosts monthly cacao circles and leads spiritual song circles.

Max McMahon, LICSW

BPS Leadership

Max is a clinical social worker with nearly 20 years of practice experience in schools, workplace/EAP, hospice and oncology care. He has specialized in serious illness care, life transitions, and working with men. Most recently Max worked as a psychedelic dosing therapist on clinical trials for treatment-resistant depression and anxiety. He has psychedelic-assisted therapy training through a Harvard–MAPS partnership and has been trained on individual protocols from sponsor companies. Max is interested in supporting community health systems in equitable and affordable access to psychedelic-assisted therapies. He chases sunshine and coastal swimming for restoration and balance.